copacetic98

Author Archives

Recent Author Comments

On Whither Facebook?
Thanks, Travis, lots of food for thought. I don't own FB, and only became a "monthly active user" a few months ago. Well, I found out I'm late to the party, as many of my Friend requests sit unrequited as a good number of my friends don't use the platfor[...]
On What the heck is "NanoCrystal Electricity?" Will it "Magically Power Everything" and "pay out 78 times your money?"
As far as I can tell, this company is a total fraud. Everything other than contact charging that they've promised has been either a violation of the laws of physics or a violation of FCC rules. The FCC approval was actually for a testing method, not for[...]
On Rodman and Renshaw Presentation Notes, Day Two
Awesome work, Dr KSS, Eyedoc, et al!![...]
On "America's Next 79,900% Growth Sector" teased by Breakthrough Technology Alert
It recovered after your comment with a good finish to close at 17.44, down 11% for the day. Any thoughts about the action tomorrow? Back down to the 12s this week, or will it hold 17? I bought some Sept 16 puts, so the 12s would be lovely if it happens [...]
On Is September 30 really "D-Day for the U.S. Dollar" as Jim Rickards is Warning?
I dunno, Barry, "Buy the rumor, sell the news" seems to work more often than not. Also, uncertainty over the election is only a problem if one outcome is significantly worse than the other. If you expect the market to go up after the election no matter t[...]
On Microblog: Antibiotics Don't Get No Respect, But You Can Still Profit From Them
Dr KSS, I just noticed that CTIX started a Phase 2 "Proof of Concept" trial for Brilacidin as a treatment for ulcerative proctitis, announced June 15, 2016. Does that mean that the Phase 2b trial you referred to in this article (27 months ago) did not go [...]
On Microblog: #4_z$FLKS_Shoez
$FLKS was thoroughly and convincingly trashed at great length today in Seeking Alpha - http://seekingalpha.com/article/3985048-flex-pharma-load-cramp Disclosure - I'm long $FLKS, but considering dumping it[...]
On What's Robinson's "Little Black Smart Box" teased for Radical Technology Profits?
Good call on STRP! Any idea what's going on with them today? +19% this afternoon[...]
On "The Death of Electric Cars" -- Oxford Club says you can make a fortune on "The Next Exxon"
Travis! Stop this thread while you can!! I've seen a lot of forums blow themselves up by following this fact-free emotional indulgence! Keep us focused on the stocks, not the back and forth of whose scientists are better fabricators and dissemblers.[...]
On What's Jason Stutman's $7 "iPhone Killer" Stock?
Yes[...]
On Special Commentary: Turbulence for Esperion
32% today. Two more 32% days and I'll be back even "Flex Pharma Positive Human NLC Study Selected for Late-Breaking Presentation at AAN Annual Meeting" http://ir.flex-pharma.com/phoenix.zhtml?c=253862&p=irol-newsArticle&ID=2148129[...]
On "Deadly Underwater International Security Threat Revealed -- Turn $1,000 into $25,400 in just the next 6 to 12 months"
Kraken recently sold a KATFISH sonar system to Elbit, the Israeli defense technology company. Elbit is a serious player, so I believe this says something positive about Kraken. A nice description of the application of the technology can be found at htt[...]
On "New Texas Oil" from Nick Hodge
No mention that Natcore has developed a process to create solar cells without using silver: http://www.printedelectronicsworld.com/articles/8333/solar-cell-that-eliminates-use-of-silver China is on target to use 100 billion ounces of silver for solar cel[...]
On 3D Printing Gen2: "The World’s Most Disruptive Growth Market is Taking Off – Again!"
Well, GE hasn't yet committed to using 3D printed part in production. But from what I understand about SGLB's process, it *may* be applicable to Carbon3D's method (see Steve's comment #9 above). (NOTE: I am not an SGLB insider, nor am I a physcist or [...]
On 3D Printing Gen2: "The World’s Most Disruptive Growth Market is Taking Off – Again!"
"Reverse Polish Notation" - gotta be correct about these and all other things! :-)[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch